Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting.
Saved in:
| Title: | Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting. |
|---|---|
| Authors: | McAteer MA; Department of Oncology, University of Oxford, Oxford, UK. martina.mcateer@oncology.ox.ac.uk., McGowan DR; Department of Oncology, University of Oxford, Oxford, UK.; Department of Medical Physics and Clinical Engineering, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Cook GJR; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.; King's College London and Guy's and St Thomas' PET Centre, St Thomas' Hospital, London, UK., Leung HY; CRUK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Ng T; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Oncology Translational Research, GSK, Stevenage, UK., O'Connor JPB; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK., Aloj L; Department of Radiology, University of Cambridge, Cambridge, UK., Barnes A; Southeast Region, Office of the Chief Scientific Officer, NHS-England, England, UK.; King's Technology Evaluation Centre (KiTEC), School of Biomedical Engineering & Imaging Science, King's College London, London, UK., Blower PJ; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Brindle KM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Braun J; RMH Radiotherapy Focus Group & RMH Biomedical Research Centre Consumer Group, Sutton, UK., Buckley C; Siemens Healthcare Limited, Camberley, UK., Darian D; Siemens Healthcare Limited, Camberley, UK., Evans P; GE HealthCare, Pharmaceutical Diagnostics, Chalfont St. Giles, UK., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.; Department of Radiology, NHS Foundation Trust, Guy's and St Thomas, London, UK., Grainger D; Medicines and Healthcare Products Regulatory Agency, London, UK., Green C; Patient and Public Representative, Oxford, UK., Hall MG; National Physical Laboratory, Teddington, UK., Harding TA; Prostate Cancer UK, London, UK.; Population Health Sciences, University of Bristol, Bristol, UK., Hines CDG; GSK, Collegeville, PA, USA., Hollingsworth SJ; Late Development Oncology, AstraZeneca, Cambridge, UK., Cristinacce PLH; Division of Cancer Sciences, University of Manchester, Manchester, UK., Illing RO; Department of Surgery & Interventional Science, University College London, London, UK., Lee M; Clinical Trial and Statistics Unit, Institute of Cancer Research, Sutton, UK.; The Royal Marsden Clinical Research Facility, London, UK., Leurent B; Department of Statistical Science, University College London, London, UK., Mallett S; Centre for Medical Imaging, University College London, London, UK., Neji R; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.; Siemens Healthcare Limited, Camberley, UK., Norori N; Prostate Cancer UK, London, UK., Pashayan N; Department of Applied Health Research, University College London, London, UK.; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Patel N; Department of Radiology, Churchill Hospital, Oxford University NHS Foundation Trust, Oxford, UK.; Telix Pharmaceuticals Limited, North Melbourne, Australia., Prior K; Cancer Research UK, London, UK., Reiner T; Evergreen Theragnostics, Springfield, NJ, 07081, USA., Retter A; Centre for Medical Imaging, University College London, London, UK., Taylor A; University Hospitals of Morecambe Bay NHS Foundation Trust, Royal Lancaster Infirmary, Lancaster, UK., van der Aart J; GSK Research and Development, Hertfordshire, UK., Woollcott J; Prostate Cancer UK, London, UK., Wong WL; PET CT Department, Strickland Scanner Centre Mount Vernon Hospital, Northwood, UK., van der Meulen J; Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Higgins GS; Department of Oncology, University of Oxford, Oxford, UK. geoffrey.higgins@oncology.ox.ac.uk. |
| Source: | BMC medicine [BMC Med] 2025 Jan 23; Vol. 23 (1), pp. 37. Date of Electronic Publication: 2025 Jan 23. |
| Publication Type: | Journal Article; Consensus Statement |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1741-7015 |
|---|---|
| DOI: | 10.1186/s12916-024-03831-z |
